Analysis of a clinical pathway for the use of long-acting injectable antiretroviral therapy in adherence challenged people living with HIV
International Journal of STD & AIDS: Clinical practice in sexual health
Published online on July 25, 2026
Abstract
International Journal of STD & AIDS, Ahead of Print.
BackgroundLong-acting injectable cabotegravir/rilpivirine (LA-CAB/RPV) is approved for people with HIV (PWH) who have achieved virological suppression; however, evidence remains limited for individuals with adherence challenges including those with ...
BackgroundLong-acting injectable cabotegravir/rilpivirine (LA-CAB/RPV) is approved for people with HIV (PWH) who have achieved virological suppression; however, evidence remains limited for individuals with adherence challenges including those with ...